Anees B. Chagpar MD, MSc, MA, MPH, MBA, FRCS(C), FACS

Associate Professor of Surgery (Oncology); Director, The Breast Center at Smilow Cancer Hospital at Yale-New Haven; Program Director, Interdisciplinary Breast Fellowship; Assistant Director, Global Oncology, Yale Comprehensive Cancer Center

Clinical Interests

breast cancer; breast health; ductal carcinoma in situ; invasive breast cancer; inflammatory breast cancer; invasive ductal carcinoma; invasive lobular carcinoma; Paget's disease; lobular carcinoma in situ; atypical hyperplasia; high risk; BRCA; nipple discharge; breast mass; mastectomy; skin-sparing mastectomy; nipple sparing mastectomy; sentinel node biopsy; Mammosite; accelerated partial breast irradiation; minimally invasive breast biopsy; axillary node dissection; lumpectomy; breast conserving surgery; personalized medicine; targeted therapy; hormonal therapy; multidisciplinary care; benign breast disease; fibroadenoma; phylloides tumor


Board Certifications

2004
Surgery, General, Board Certified

Patient Care Locations

anees_chagparfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Breast - Female and Breast - MaleRandomized Phase II trial of Neoadjuvant Cisplatin vs. Doxorubicin/Cyclophosphamide (AC) in Women with Newly Diagnosed Breast Cancer and Germline BRCA Mutations
Breast - FemaleSINGLE ARM, NEOADJUVANT, PHASE II TRIAL OF PERTUZUMAB AND TRASTUZUMAB ADMINISTERED CONCOMITANTLY WITH WEEKLY PACLITAXEL AND FEC FOR CLINICAL STAGE I-III HER2-POSITIVE BREAST CANCER
Breast Cancer, Cancer, and Breast - FemaleExamination of Epigenetic Changes in Breast Tissue and Peripheral Blood of Women at Average versus Increased Risk of Breast Cancer
Breast - FemaleA Pilot Pre-operative Window Trial of Black Cohosh in Women with Ductal Carcinoma in situ
Unknown SitesNovel Treatment to Enhance Smoking Cessation before Cancer Surgery

More Clinical Trials...

Edit Profile